Inventor
FRESKOS JOHN N
US116 patents
⚠️ This page may combine multiple inventors who share the name “FRESKOS JOHN N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
43 patentsUS6248775B1Jun 19, 2001
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO129 citations99
US6060476AMay 9, 2000
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO77 citations97
US5843946ADec 1, 1998
α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO78 citations97
US6534493B1Mar 18, 2003
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO26 citations96
US6500832B1Dec 31, 2002
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO21 citations96
US6472407B1Oct 29, 2002
α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO21 citations96
US6455581B1Sep 24, 2002
α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO20 citations96
US6335460B1Jan 1, 2002
α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO28 citations96
US6172082B1Jan 9, 2001
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO24 citations96
US5968942AOct 19, 1999
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO61 citations96
US5965588AOct 12, 1999
Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors
SEARLE & CO66 citations96
US5786483AJul 28, 1998
α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO26 citations96
US5760064AJun 2, 1998
Sulfonylalkanoylamino hydroxyethylamino sulfanamides useful as retroviral protease inhibitors
SEARLE & CO40 citations96
US5744481AApr 28, 1998
β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO51 citations96
US5639769AJun 17, 1997
Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO36 citations96
US5521219AMay 28, 1996
Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO54 citations96
US5508294AApr 16, 1996
Sulfonylalkanoylamino hydroxyethlamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO41 citations96
US7115618B2Oct 3, 2006
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO12 citations93
US6924286B1Aug 2, 2005
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO16 citations93
US6846954B2Jan 25, 2005
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO16 citations93
US6646010B2Nov 11, 2003
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO16 citations93
US6417387B1Jul 9, 2002
α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO24 citations93
US6384036B1May 7, 2002
Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
SEARLE & CO22 citations93
US6313345B1Nov 6, 2001
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO19 citations93
US6143747ANov 7, 2000
Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
SEARLE & CO21 citations93
US6046190AApr 4, 2000
Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
SEARLE & CO43 citations93
US6022994AFeb 8, 2000
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO23 citations93
US5830897ANov 3, 1998
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO47 citations93
US5776971AJul 7, 1998
Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
SEARLE & CO19 citations93
US5760076AJun 2, 1998
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO32 citations93
US5756533AMay 26, 1998
Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
SEARLE & CO24 citations93
US5705500AJan 6, 1998
Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
SEARLE & CO26 citations93
US5703076ADec 30, 1997
Retroviral protease inhibitors
SEARLE & CO23 citations93
US5610190AMar 11, 1997
Retroviral protease inhibitors
SEARLE & CO27 citations93
US5510349AApr 23, 1996
Retroviral protease inhibitors
SEARLE & CO28 citations93
US5510388AApr 23, 1996
Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO27 citations93
US5475027ADec 12, 1995
Retroviral protease inhibitors
SEARLE & CO21 citations93
US5463104AOct 31, 1995
Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO23 citations93
US5753660AMay 19, 1998
Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
SEARLE & CO24 citations92
US7115632B1Oct 3, 2006
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
SEARLE & CO33 citations91
US6150556ANov 21, 2000
Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
SEARLE & CO25 citations91
US6541489B1Apr 1, 2003
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
SEARLE & CO21 citations90
US7141609B2Nov 28, 2006
α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
SEARLE & CO13 citations84
MONSANTO CO
3 patentsPHARMACIA CORP
2 patents(unassigned)
1 patentETHYL CORP
1 patentShowing the top 50 of 116 patents by PatentIndex Score.